Atea Pharmaceuticals (AVIR) Net Margin: 2021

Historic Net Margin for Atea Pharmaceuticals (AVIR) over the last 1 years, with Dec 2021 value amounting to 60.95%.

  • Atea Pharmaceuticals' Net Margin was N/A to 60.95% in Q4 2021 from the same period last year, while for Dec 2021 it was 34.49%, marking a year-over-year change of. This contributed to the annual value of 34.49% for FY2021, which is 5700.00% up from last year.
  • Latest data reveals that Atea Pharmaceuticals reported Net Margin of 60.95% as of Q4 2021, which was up 170.93% from -85.93% recorded in Q3 2021.
  • In the past 5 years, Atea Pharmaceuticals' Net Margin registered a high of 60.95% during Q4 2021, and its lowest value of -85.93% during Q3 2021.
  • Over the past 1 years, Atea Pharmaceuticals' median Net Margin value was 24.55% (recorded in 2021), while the average stood at 6.03%.